Granules India receives EU GMP approval for Visakhapatnam facility
Capital MarketGranules India announced that the company's Unit-V, high potent API and Finished Formulations manufacturing facility located at Visakhapatnam, Andhra Pradesh, India has received EU GMP approval. This approval is valid for three years.
This facility was audited in the month of January 2020 for good manufacturing practices of API and Oral solid dosage.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
